Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: August 1, 2025

  • Open
    34.38
  • High
    36.05
  • Low
    33.09
  • Close
    35.63
  • Volume
    962,794

Financial ratios

Dec 31, 2024